The effect of auxiliary treatment of COPD with hydrogen-oxygen mixture has been confirmed, and hydrogen medicine will face a new development.
The 5th Hydrogen and Health Industry Development Forum was held in Beijing a few days ago. Xu Kecheng, president of Fudan Cancer Hospital affiliated to Jinan University, Sun Xuejun, a naval medical research scholar of the Second Military Medical University, and other hydrogen medical experts and industry leaders gathered together to share the latest achievements of hydrogen medicine.
New study: Hydrogen becomes an acute exacerbation of chronic obstructive pulmonary disease to treat "assistant attacker"
According to the experts attending the meeting, in mid-May, the clinical trial results of Academician Zhong Nanshan's team on the treatment of acute exacerbation caused by chronic obstructive pulmonary disease with hydrogen-oxygen mixture were published in the British journal Respiratory Research. The trial found that hydrogen-oxygen therapy was superior to oxygen therapy and had acceptable safety and tolerance for patients with chronic obstructive pulmonary disease.
Severe dyspnea and acute exacerbation are the main causes of death of chronic obstructive pulmonary disease (CPOD), and bronchodilators, noninvasive ventilation and oxygen therapy are the main treatment methods at present. hydrogen absorption therapy is called hydrogen medicine in the industry, and nearly 2,000 research papers have been published worldwide for 14 years since 2007. A large number of studies have proved that hydrogen molecules have the characteristics of anti-inflammation, anti-oxidation and oxygen dispersion. So, in the field of acute exacerbation of COPD, is the effect of mixed inhalation of hydrogen and oxygen better than that of oxygen inhalation alone? This study shows that, compared with oxygen therapy alone, inhalation of hydrogen/oxygen mixture can significantly improve the symptoms of acute exacerbation of COPD (including dyspnea, cough and expectoration), and it may be used as an auxiliary treatment for acute exacerbation of chronic obstructive pulmonary disease.
This conference made an in-depth discussion on the effect of hydrogen in the field of lung disease control. Previously, hydrogen therapy has played a unique role in the diagnosis and treatment of COVID-19. In 2020, "novel coronavirus Treatment Plan (Trial 7th Edition) (Trial 8th Edition)" issued by the National Health and Health Commission added "mixed inhalation of hydrogen and oxygen (H2/O2: 66.6%/33.3%) can be used for treatment when conditions permit"
New prospect: Hydrogen-oxygen mixture is expected to make some tumors more stable in the middle and late stages.
The research and application of hydrogen-assisted tumor therapy are gradually emerging. "Cancer Control by Hydrogen: Theory and Practice", edited by Professor Xu Kecheng, Dean of Fudan Cancer Hospital affiliated to Jinan University, and reviewed by Tang Zhaoyou, academician of China Academy of Engineering and famous oncologist, was published in Guangzhou. According to the book, in the follow-up comparison of 82 tumor patients' treatment and rehabilitation, it was found that the tumor volume stabilization rate of some tumor patients reached 84% and 49% in the third and fourth clinical stages, respectively.
This discovery attracted the attention of the medical scientific community, and also attracted hydrogen producers in the hydrogen energy industry to flood into the market instantly. Many health centers and equipment vendors for the elderly emerged one after another, claiming to be able to provide hydrogen anticancer treatment. Lin Xinyong, the supplier of research equipment for hydrogen-oxygen mixed therapy chronic obstructive pulmonary disease and CEO of Shanghai Yumei Medical Technology Co., Ltd., reminded that based on the combustible and explosive nature of hydrogen, the molecules of accessory materials are easily decomposed and inhaled into the body, causing liver and kidney damage and the biological action principle of hydrogen molecules entering the nucleus to reduce malignant free radicals. At present, China, the European Union, Japan and other countries are listed in the strictest three types of medical device standard management according to their high risk, implantation and invasion characteristics. The majority of patients must choose the products that have been legally listed through the safety type test of the State Food and Drug Administration. Follow the doctor's advice and choose a regular medical institution or place to complete the hydrogen treatment, so as to avoid accidentally inhaling industrial hydrogen and even encountering potential safety hazards such as hydrogen explosion.
Lin Yong further shared that most chronic diseases come from long-term inflammatory reaction and oxidative stress damage of cells. A large number of studies have shown that hydrogen molecules have strong anti-inflammatory and antioxidant effects, and Academician Zhong Nanshan's team was the first to participate in scientific research and discover its clinical application value. Hydrogen and oxygen medicine has a long way to go in chronic diseases such as COPD, asthma, bronchiectasis, ground glass of pulmonary nodules, etc. Shanghai Yumei Medical Association focuses on reducing the burden of medical insurance for the country and providing more protection for people's health through commercial insurance as soon as possible.
Sun Xuejun, a research scholar of naval aviation medicine in the Second Military Medical University, stressed that although hydrogen therapy may be effective, we must listen to the advice of professional doctors and not give up standardized treatment during the treatment.